Mirvaso

Medicinal product

(Invented) name

Mirvaso

Active substance (s)

Brimonidinas

Strength

3 mg/g

Pharmaceutical form

gelis

Route (s) of administration

vartoti ant odos

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

D11AX21, Brimonidine

Marketing authorisation holder

Galderma International, Prancūzija

Date of authorisation

2014-02-21

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Gel	1 g
Brimonidinas	3 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
61159	75473	1075473	tūbelė	2 g N1 (PE/EAA kopolimero/Alu/EAA kopolimero/PE)		Receptinis	EU/1/13/904/004	Netiekiama	-	-	No	-	-
61160	75474	1075474	tūbelė	10 g N1 (PE/EAA kopolimero/Alu/EAA kopolimero/PE)		Receptinis	EU/1/13/904/005	Netiekiama	-	-	No	-	-
61161	75475	1075475	tūbelė	30 g N1 (PE/EAA kopolimero/Alu/EAA kopolimero/PE)		Receptinis	EU/1/13/904/006	Netiekiama	-	-	No	-	-
67803	82360	1082360	daugiadozė talpyklė su pompa	30 g N1 (PP/TPO/DTPE)		Receptinis	EU/1/13/904/007	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-02-21	Registruotas